Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.

@article{Garcs2014FactorsIR,
  title={Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.},
  author={Mercedes Garc{\'e}s and Vicente Villanueva and Jos{\'e} Angel Mauri and Ana Suller and Carolina Paola Garc{\'i}a and Franscisco Javier L{\'o}pez Gonz{\'a}lez and Xiana Rodr{\'i}guez Osorio and Gustavo Fern{\'a}ndez Pajar{\'i}n and Anna Piera and Edelmira Guillam{\'o}n and Consuelo Santaf{\'e} and Ascensi{\'o}n Castillo and Pau Giner and Nerea Torres and In{\'e}s Escalza and Ana del Villar and Maria Carmen Garc{\'i}a de Casasola and Macarena Bonet and Enrique No{\'e} and Nuria Olmedilla},
  journal={Epilepsy & behavior : E&B},
  year={2014},
  volume={36},
  pages={144-52}
}
Status epilepticus (SE) and acute repetitive seizures (ARSs) frequently result in emergency visits. Wide variations in response are seen with standard antiepileptic drugs (AEDs). Oral and intravenous (IV) formulations of lacosamide are approved as adjunctive therapy in the treatment of partial-onset seizures in adults and adolescents. The aim of the retrospective multicenter observational study (LACO-IV) was to analyze data from a large cohort of patients with SE or ARSs of varying severity and… CONTINUE READING